Cargando…
Correction to: Moxetumomab Pasudotox: First Global Approval
Autor principal: | Dhillon, Sohita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338709/ https://www.ncbi.nlm.nih.gov/pubmed/30612318 http://dx.doi.org/10.1007/s40265-018-1049-5 |
Ejemplares similares
-
Moxetumomab Pasudotox: First Global Approval
por: Dhillon, Sohita
Publicado: (2018) -
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
por: Kreitman, Robert J., et al.
Publicado: (2018) -
Correction to: Ivosidenib: First Global Approval
por: Dhillon, Sohita
Publicado: (2019) -
Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox
por: Robak, Tadeusz, et al.
Publicado: (2021) -
Correction to: Lonafarnib: First Approval
por: Dhillon, Sohita
Publicado: (2021)